Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:1286
SEHK:1286Machinery

Impro Precision Industries (SEHK:1286) Margin Improvement Tests Bullish Growth Narratives

Impro Precision Industries (SEHK:1286) has reported FY 2025 first half revenue of HK$2,449.9 million and basic EPS of HK$0.18, with trailing twelve month revenue at HK$5.1 billion and EPS at HK$0.39 framing the latest numbers in a broader context. Over the last three reported half year periods, revenue has moved from HK$2,402.5 million in 1H 2024 to HK$2,284.3 million in 2H 2024 and then to HK$2,449.9 million in 1H 2025, while basic EPS has shifted from HK$0.16 to HK$0.18 over the same span,...
NYSE:WLY
NYSE:WLYMedia

Assessing Wiley (WLY) Valuation After Q3 Profit Rebound AI Growth And Buybacks

John Wiley & Sons (WLY) is back in focus after reporting fiscal third quarter earnings that returned the business to profitability, alongside steady revenue, expanding AI driven research offerings, and active share repurchases. See our latest analysis for John Wiley & Sons. The recent Q3 profit rebound and ongoing buybacks appear to have shifted sentiment, with a 25.21% 1 month share price return and a 24.10% year to date share price return, even though the 1 year total shareholder return is...
SEHK:127
SEHK:127Real Estate

Chinese Estates Holdings (SEHK:127) Losses Near HK$400 Million Reinforce Bearish Narratives

Chinese Estates Holdings (SEHK:127) has reported FY 2025 first half revenue of HK$42.7 million, with basic EPS at a loss of HK$0.215 per share as the group continues to work through a weak earnings patch. The company has seen revenue move from HK$183.9 million in the first half of 2024 to HK$41.8 million in the second half of 2024 and HK$42.7 million in the latest period. Basic EPS losses shifted from HK$0.221 to HK$0.884 and then HK$0.215, setting up an earnings season where investors may...
NYSE:UHS
NYSE:UHSHealthcare

Is Universal Health Services (UHS) Attractive After Recent Pullback In Share Price

If you are wondering whether Universal Health Services is offering fair value at around US$186.53, you are not alone. This article focuses on what the numbers say about the stock today. The share price has pulled back recently, with an 8.9% decline over the last 7 days and a 14.7% decline over the last 30 days. However, the 1 year and 3 year returns of 8.5% and 62.2% respectively still stand out. Recent news around Universal Health Services has focused on the company as a key player in the...
CPSE:MAERSK B
CPSE:MAERSK BShipping

Assessing A.P. Møller - Mærsk (CPSE:MAERSK B) Valuation After Strait Of Hormuz Route Suspensions

A.P. Møller - Mærsk (CPSE:MAERSK B) has temporarily suspended several shipping services connecting the Middle East with Europe and Asia, after the closure of the Strait of Hormuz created fresh security and fuel distribution challenges. See our latest analysis for A.P. Møller - Mærsk. The latest news comes after a choppy period for the stock. The 1-day share price return shows a decline of 1.39% and the 7-day share price return shows a decline of 5.88%. This is set against a 30-day share price...
TSE:9678
TSE:9678Trade Distributors

Kanamoto (TSE:9678) Q1 EPS Jump Challenges Cautious Growth Narratives

Kanamoto (TSE:9678) opened its Q1 2026 scorecard with revenue of ¥55.2 billion and basic EPS of ¥106.72, setting the tone for how the new fiscal year is starting to shape up. The company has seen quarterly revenue move from ¥52.6 billion and EPS of ¥73.74 in Q1 2025 to ¥55.2 billion and EPS of ¥106.72 in the latest quarter, with the trailing twelve month EPS at ¥328.86 on revenue of ¥214.8 billion. For investors, the mix of higher recent EPS prints and a steady revenue base highlights...
NYSE:EIX
NYSE:EIXElectric Utilities

Edison Lawsuit Win Refocuses Attention On Wildfire Liabilities And Valuation

Edison International (NYSE:EIX) secured a dismissal of a shareholder lawsuit challenging its wildfire risk disclosures. The case focused on statements made before the January 2025 Los Angeles wildfires. The ruling removes a specific litigation claim tied to how the company communicated wildfire exposure to investors. Edison International, the parent of Southern California Edison, sits at the center of ongoing debates around utility wildfire exposure and risk management in California. The...
NYSE:MO
NYSE:MOTobacco

Evaluating Altria Group (MO) After Recent Share Price Momentum And Mixed Valuation Signals

Altria Group (MO) is back on investors’ radar after recent share price moves, with the stock last closing at $67.14. You might be weighing how its returns and fundamentals currently line up. See our latest analysis for Altria Group. The latest move to $67.14 comes after a 14.4% 90 day share price return and a 17.15% year to date share price return, with a 1 year total shareholder return of 23.74% indicating solid momentum over a longer horizon. If this has you thinking about where else...
NYSE:NWN
NYSE:NWNGas Utilities

Assessing Northwest Natural Holding (NWN) Valuation After A Strong Year Of Shareholder Returns

Event context and recent performance Northwest Natural Holding (NWN) has drawn investor attention after recent trading, with the stock closing at US$51.62 and showing mixed short term moves, including a 1 day decline and a gain over the past month. See our latest analysis for Northwest Natural Holding. That 1 day share price pullback sits against a firmer backdrop, with a 30 day share price return of 7.39%, year to date gain of 10.44%, and a 1 year total shareholder return of 30.13%,...
NasdaqGS:SATS
NasdaqGS:SATSMedia

EchoStar (SATS) Valuation After Spectrum Sale To AT&T And SpaceX And Upcoming EchoStar XXV Launch

EchoStar (SATS) is in the spotlight after selling US$42.65b of spectrum to AT&T and SpaceX. The company is cutting net debt and bankruptcy risk, while preparing the EchoStar XXV launch and reshaping its Pay TV and Broadband operations. See our latest analysis for EchoStar. The share price is at US$108.50 after a 7 day share price return of a 7.19% decline and a 90 day share price return of a 4.35% gain. The 1 year total shareholder return of just over 3x suggests powerful longer term...
NYSE:ALB
NYSE:ALBChemicals

Has Albemarle (ALB) Run Too Far After 134% One-Year Share Price Surge?

Wondering whether Albemarle's current share price gives you a fair deal, or if the market is mispricing the stock? This article focuses on what the numbers say about value rather than the hype. Albemarle's share price last closed at US$166.54, with returns of 1.1% over 7 days, 1.9% over 30 days, 15.7% year to date, 133.9% over 1 year, negative 22.7% over 3 years and 13.4% over 5 years. Taken together, these figures give you a mixed picture of recent and longer term performance. Recent...
NYSE:DG
NYSE:DGConsumer Retailing

Is Dollar General (DG) Still Attractively Priced After Mixed Share Price Performance?

If you are wondering whether Dollar General's share price around its recent US$146 close still offers value, you are not alone. This article is built to help you weigh what that price might actually represent. The stock has had a mixed run, with a 4.6% decline over the last 7 days, a 0.4% decline over 30 days, but a 6.7% gain year to date and an 89.7% return over the past year, set against 3-year and 5-year returns of 28.0% and 18.4% declines respectively. Recent coverage of Dollar General...
NYSE:HL
NYSE:HLMetals and Mining

Does Hecla’s Shift Toward Silver Amid Market Deficit Expectations Change The Bull Case For HL?

In recent days, Hecla Mining reported that its fortunes have swung with precious metal prices, as weaker gold but stronger silver prices, alongside a firmer US dollar and rising interest rates, pulled its operations and investor sentiment in different directions. At the same time, management has intensified the company’s focus on silver by selling gold assets and boosting silver exploration and pre-development activity, tying Hecla’s outlook even more closely to conditions in the silver...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly Auditor Switch To KPMG Raises Questions On Rally And Valuation

Fastly has appointed KPMG as its new independent registered public accounting firm, replacing Deloitte & Touche LLP. The change in auditor represents a shift in the company’s oversight of financial reporting and internal controls. For investors tracking NasdaqGS:FSLY, this auditor switch comes at a time when the stock price is $22.74 and recent returns have been very strong. The shares show a 7.6% return over the past week, 165.3% over the past month, 123.2% year to date, and 245.6% over...
XTRA:RHM
XTRA:RHMAerospace & Defense

Is Rheinmetall (XTRA:RHM) Still Attractive After Its 44% One Year Share Price Gain?

If you are wondering whether Rheinmetall's recent share price puts it on your watchlist or in the too expensive pile, the key question is what you are actually paying for at today’s levels. With the stock last closing at €1,653.00 and returns of 4.6% over 7 days, 3.0% over 30 days, 3.2% year to date and 44.0% over 1 year, many investors are asking whether the current price still reflects a reasonable entry point or if expectations have already been priced in. Recent headlines around...
NYSE:FLS
NYSE:FLSMachinery

Is Flowserve (FLS) Still Attractive After A 69% One Year Share Price Surge?

If you are wondering whether Flowserve's current share price still offers value after a strong run, you are not alone. This article will walk through how the market might be pricing the stock today. Flowserve shares last closed at US$78.71, with returns of 68.7% over 1 year and 11.3% year to date, even though the stock has seen a 5.7% decline over 7 days and a 7.9% decline over 30 days. Recent coverage around Flowserve has focused on the business as an established player in the capital goods...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test

Quest Diagnostics (NYSE:DGX) has partnered with Guardant Health to offer the FDA approved Shield blood test for colorectal cancer screening. The agreement will make Shield available nationwide through Quest’s testing ecosystem, expanding access for patients and clinicians. The collaboration focuses on a blood based option for colorectal cancer screening that may support broader adoption of preventive care. For you as an investor, this move plugs directly into what Quest Diagnostics already...
NYSE:NOW
NYSE:NOWSoftware

Is ServiceNow (NOW) Pricing Reflect Its Recent Slide And Large Cap Tech Sentiment Shift

If you are wondering whether ServiceNow's current share price lines up with its underlying worth, you are not alone. This article is going to focus squarely on that question. The stock last closed at US$116.61, with returns of 3.0% over 7 days and 15.8% over 30 days. This is set against a year to date return of a 20.9% decline and a 1 year return of a 27.9% decline, while the 3 year and 5 year returns sit at 37.3% and 16.8% respectively. Recent news coverage around ServiceNow has focused on...
NYSE:EPAM
NYSE:EPAMIT

Is It Time To Reassess EPAM Systems (EPAM) After Its Extended Share Price Slide?

If you are wondering whether EPAM Systems is starting to look like value after a tough run, this breakdown will help you frame the price you see against what you are actually getting. The stock last closed at US$142.18, with a 1% gain over the past week but declines of 23.8% over 30 days, 29.1% year to date and 25.7% over the past year, extending a 50.2% 3 year and 61.7% 5 year slide. Recent coverage around EPAM Systems has largely focused on its position within the software and IT services...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Gilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification

Gilead Sciences (NasdaqGS:GILD) plans to acquire Arcellx in a deal valued at up to $7.8b. The transaction is aimed at expanding Gilead's cancer cell therapy pipeline, especially in multiple myeloma. The deal is expected to close in the second quarter of 2026, subject to customary approvals. Gilead Sciences, trading at $148.56, has seen a 22.2% return year to date and a 33.5% return over the past year. Over longer periods, the stock has recorded a 105.0% return over three years and 178.0%...
NasdaqGS:SONO
NasdaqGS:SONOConsumer Durables

Is It Time To Reconsider Sonos (SONO) After Its Recent Share Price Volatility

If you are wondering whether Sonos at US$14.23 is an opportunity or a value trap, you are in the right place for a clear look at what the current price actually reflects. The stock has had a mixed ride, with a 16.7% decline over the past month and an 18.6% decline year to date, yet it is still up 21.5% over the last year after a much weaker 3 and 5 year return picture. Recent attention on Sonos has focused on its position in consumer audio hardware, including interest in how its product...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Assessing Sandisk (SNDK) Valuation After A Strong Multi‑Month Share Price Run

What Sandisk’s Recent Performance Tells You With no single headline event driving attention, Sandisk (SNDK) has still drawn interest after a 5.1% move in the past day and a very large total return over the past 3 months. See our latest analysis for Sandisk. That 5.1% 1 day share price return at a last close of $618.89 comes on top of a 9.5% 7 day and 3.5% 30 day share price return. The roughly 17x 1 year total shareholder return implies investors have rapidly reassessed Sandisk’s prospects...
NYSE:SCCO
NYSE:SCCOMetals and Mining

A Look At Southern Copper (SCCO) Valuation After Analyst Downgrades And Insider Selling

Southern Copper (SCCO) is back in focus after a 3.60% share price drop, which has been linked to weaker copper prices, cautious economic signals from China, analyst downgrades, and insider selling following strong quarterly earnings. See our latest analysis for Southern Copper. Zooming out, Southern Copper’s recent weakness, with a 7 day share price return of negative 4.88% and 30 day share price return of negative 1.11%, sits against a much stronger backdrop. This includes a 90 day share...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Valuation Check After Raymond James Conference And Growth Project Updates

Royal Gold (RGLD) has come back into focus after its appearance at the 47th Annual Raymond James Institutional Investor Conference, where management highlighted operational efficiency, dividend consistency, and future growth projects including Platreef, MARA, and Four Mile. See our latest analysis for Royal Gold. Royal Gold’s recent conference appearance and dividend affirmation come against a backdrop of stronger price action, with a 30 day share price return of 5.99%, a 90 day share price...